Moderna, Inc. develops and commercializes mRNA-based medicines, focusing on addressing infectious and serious diseases. The company utilizes its mRNA platform to accelerate drug discovery and development, supported by its mRNA Design Studio for rapid research and testing. Moderna operates primarily in the biotechnology sector, serving healthcare providers and patients globally, with its headquarters located in Cambridge, Massachusetts.
| MRNA | MRNA | Shares | USD | XNGS |
| MRNA | MRNA | Shares | USD | XNGS |
No recent RNS announcements for 1MRNA across 1MRNA, 2MRNA, 4MRNA, MRNA.
No recent RNS announcements for 1MRNA across 1MRNA, 2MRNA, 4MRNA, MRNA.